FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992151127> ?p ?o ?g. }

• W1992151127 endingPage "1466" @default.
• W1992151127 startingPage "1458" @default.
• W1992151127 abstract "Given the promising control of bladder cancer achieved by combined chemotherapy/radiotherapy with selective transurethral resection, obstacles remain to the treatment of unresectable bladder cancer. The aim of this study was to determine whether targeting epidermal growth factor receptor (EGFR)/human epidermal growth factor receptor 2 (HER2) can radiosensitise a murine bladder tumour (MBT-2) cell line. Cell survival, expression of signal proteins and cell cycle changes in MBT-2 cells treated in vitro and in vivo with afatinib, an irreversible EGFR/HER2 inhibitor, plus radiotherapy were investigated by colony formation assay, Western blot assay and flow cytometry, respectively. Ectopic xenografts were established by subcutaneous injection of MBT-2 cells in C3H/HeN mice. Mice were randomised into 4 groups to receive afatinib (10 mg/kg/day on day 1–7) and/or radiotherapy (15 Gy on day 4). Positron emission tomography (PET) on day 8 was used to evaluate the early treatment response. Afatinib (200–1000 nM) increased cell killing by radiation (0–10 Gy). Pre-treatment of irradiated cells with afatinib inhibited radiation-activated HER2 and EGFR phosphorylation. As compared to either treatment alone, the combination increased the level of the cleavage form of poly (ADP-ribose) polymerase, the expression of phospho-γH2AX and the percentage of cells in subG1 phase (indicating enhanced induction of apoptosis), and decreased tumour metabolism and inhibited tumour growth by 64%. Afatinib has therapeutic value as a radiosensitiser of murine bladder cancer cells. The synergism between afatinib and radiation likely enhances DNA damage, leading to increased cell apoptosis." @default.
• W1992151127 created "2016-06-24" @default.
• W1992151127 creator A5004699298 @default.
• W1992151127 creator A5011246396 @default.
• W1992151127 creator A5026431002 @default.
• W1992151127 creator A5030951075 @default.
• W1992151127 creator A5044141560 @default.
• W1992151127 creator A5058791191 @default.
• W1992151127 creator A5067738504 @default.
• W1992151127 creator A5081982339 @default.
• W1992151127 date "2013-04-01" @default.
• W1992151127 modified "2023-09-26" @default.
• W1992151127 title "Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma" @default.
• W1992151127 cites W1534638110 @default.
• W1992151127 cites W1952252771 @default.
• W1992151127 cites W1954280969 @default.
• W1992151127 cites W1964071325 @default.
• W1992151127 cites W1976504918 @default.
• W1992151127 cites W1978522222 @default.
• W1992151127 cites W1983648619 @default.
• W1992151127 cites W1985775217 @default.
• W1992151127 cites W1985950314 @default.
• W1992151127 cites W2003601710 @default.
• W1992151127 cites W2003952757 @default.
• W1992151127 cites W2006040105 @default.
• W1992151127 cites W2014937462 @default.
• W1992151127 cites W2027557150 @default.
• W1992151127 cites W2036225171 @default.
• W1992151127 cites W2063391304 @default.
• W1992151127 cites W2064561270 @default.
• W1992151127 cites W2067162187 @default.
• W1992151127 cites W2092785855 @default.
• W1992151127 cites W2094284800 @default.
• W1992151127 cites W2104878296 @default.
• W1992151127 cites W2128083919 @default.
• W1992151127 cites W2128452890 @default.
• W1992151127 cites W2129508578 @default.
• W1992151127 cites W2139386472 @default.
• W1992151127 cites W2140858291 @default.
• W1992151127 cites W2145553893 @default.
• W1992151127 cites W2148936981 @default.
• W1992151127 cites W2152905269 @default.
• W1992151127 cites W2153156618 @default.
• W1992151127 cites W2155384808 @default.
• W1992151127 cites W2160300997 @default.
• W1992151127 cites W2165948908 @default.
• W1992151127 cites W21899765 @default.
• W1992151127 doi "https://doi.org/10.1016/j.ejca.2012.10.020" @default.
• W1992151127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23153706" @default.
• W1992151127 hasPublicationYear "2013" @default.
• W1992151127 type Work @default.
• W1992151127 sameAs 1992151127 @default.
• W1992151127 citedByCount "27" @default.
• W1992151127 countsByYear W19921511272013 @default.
• W1992151127 countsByYear W19921511272014 @default.
• W1992151127 countsByYear W19921511272015 @default.
• W1992151127 countsByYear W19921511272016 @default.
• W1992151127 countsByYear W19921511272018 @default.
• W1992151127 countsByYear W19921511272019 @default.
• W1992151127 countsByYear W19921511272020 @default.
• W1992151127 countsByYear W19921511272021 @default.
• W1992151127 countsByYear W19921511272023 @default.
• W1992151127 crossrefType "journal-article" @default.
• W1992151127 hasAuthorship W1992151127A5004699298 @default.
• W1992151127 hasAuthorship W1992151127A5011246396 @default.
• W1992151127 hasAuthorship W1992151127A5026431002 @default.
• W1992151127 hasAuthorship W1992151127A5030951075 @default.
• W1992151127 hasAuthorship W1992151127A5044141560 @default.
• W1992151127 hasAuthorship W1992151127A5058791191 @default.
• W1992151127 hasAuthorship W1992151127A5067738504 @default.
• W1992151127 hasAuthorship W1992151127A5081982339 @default.
• W1992151127 hasConcept C121608353 @default.
• W1992151127 hasConcept C126322002 @default.
• W1992151127 hasConcept C170493617 @default.
• W1992151127 hasConcept C190283241 @default.
• W1992151127 hasConcept C2776362946 @default.
• W1992151127 hasConcept C2776996007 @default.
• W1992151127 hasConcept C2778820342 @default.
• W1992151127 hasConcept C2779438470 @default.
• W1992151127 hasConcept C2780580887 @default.
• W1992151127 hasConcept C2780586478 @default.
• W1992151127 hasConcept C2781018059 @default.
• W1992151127 hasConcept C29537977 @default.
• W1992151127 hasConcept C42362537 @default.
• W1992151127 hasConcept C47170353 @default.
• W1992151127 hasConcept C502942594 @default.
• W1992151127 hasConcept C55493867 @default.
• W1992151127 hasConcept C71924100 @default.
• W1992151127 hasConcept C86803240 @default.
• W1992151127 hasConceptScore W1992151127C121608353 @default.
• W1992151127 hasConceptScore W1992151127C126322002 @default.
• W1992151127 hasConceptScore W1992151127C170493617 @default.
• W1992151127 hasConceptScore W1992151127C190283241 @default.
• W1992151127 hasConceptScore W1992151127C2776362946 @default.
• W1992151127 hasConceptScore W1992151127C2776996007 @default.
• W1992151127 hasConceptScore W1992151127C2778820342 @default.
• W1992151127 hasConceptScore W1992151127C2779438470 @default.
• W1992151127 hasConceptScore W1992151127C2780580887 @default.

• next